Josh Felker retweeted
Yesterday, we announced Arbora, our new genetics facility in Squamish, BC.
This facility will give our library of more than 500 unique cultivars a dedicated home for preservation, propagation and continued development.
Learn more:
rubiconorganics.com/news/rub…
Josh Felker retweeted
Companies say all kinds of stuff and our job as investors is to assess their credibility in the context of the world as we understand it
I think it's worth highlighting the comments below as NOT throwaway lines, but rather important and true
$VFF
Most leveraged company to Ohio.
Vext Science Earnings + Call Notes
#CannabisConfidential 🇺🇸 🌿/position+ $VEXT.CN
toddharrison.substack.com/p/…
208
Josh Felker retweeted
Rubicon Organics to Report Q3 2026 Results
$ROMJ.NE $ROMJ $ROMJF
Join us on November 16th for a conference call to discuss our most recent results. Click the link below to pre-register.
rubiconorganics.com/news/rub…
Full CB1 5 Questions with @MargaretRBrodie of @RubiconOrganics - The Importance of Genetics
youtu.be/FAXZMsGRAjs?si=-GtM…
4
474
Full CB1 5 Questions with @MargaretRBrodie of @RubiconOrganics - Forward International Trends
youtu.be/0s9nOAN8PZs?si=lzjM…
3
353
Full CB1 5 Questions with @MargaretRBrodie of @RubiconOrganics - Cascadia Facility Ramp
youtu.be/zVuVN0IvpTs?si=Z1Sv…
2
281
CB1 Capital 5 Questions with @MargaretRBrodie of @RubiconOrganics - Demand for Additional Capacity
youtu.be/avRJIUKVZxo?si=P7i8…
3
355
Transcript + clips available here
CB1 Capital: Five Questions with Rubicon Organics
Rubicon Organics CEO Margaret Brodie offers her take.
#CannabisConfidential 🤝 @RubiconOrganics $ROMJ.NE
toddharrison.substack.com/p/…
2
219
CB1 Capital 5 Questions with @MargaretRBrodie of @RubiconOrganics - $3m Raise Strategy
youtu.be/Sl-U1hxmCck?si=jWVa…
2
505
youtu.be/BMkFi3yGjmQ?si=8cWY…
Dont play cards with Satan!
I thought we all learned this by now?
1
283
Josh Felker retweeted
$HITI $VFF $MSOS In the recent VFF analyst report by Beacon, Doug Cooper talks about Germany.
"We believe Germany could still be in the very early stages of it's growth cycle. If we compare to Florida whose medical market is more mature, we can see that Germany can grow to over 3X its present size."
Recently in a podcast, Raj Grover, CEO of High Tide, said that Germany medical is going to be much larger than he previously thought so this is aligning.
This lines up with my future German sales projections of C$400-500 million for Remexian from the current C$150 million run rate.
Gross Margins will be 25-30% with 15% (+/-) EBITDA margins.
